HOME › DRUGS › ADAGRASIB
ACTIVE SUBSTANCE / INN

ADAGRASIB

Brand name(s): KRAZATI, Krazati
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Carcinoma, Non-Small-Cell Lung
NDA216340
ACTIVE SUBSTANCE
Adagrasib
REGULATORS
FDA · EMA
SPONSORS / MAH
BRISTOL, Bristol-Myers Squibb Pharma EEIG
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KRAZATINDA216340BRISTOLPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KrazatiBristol-Myers Squibb Pharma EEIGAuthorised05/01/2024Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON ADAGRASIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →